Proteases: Essential actors in processing antigens and intracellular toll-like receptors

Frontiers in Immunology

Volumn 4, Issue SEP, 2013, Pages

  Manoury, Bénédicte ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Antigen processing; Endosomal proteases; Intracellular toll like receptors; MHC class II

Indexed keywords

BRUTON TYROSINE KINASE; CATHEPSIN G; CATHEPSIN L; CATHEPSIN S; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN BASIC PROTEIN; PROTEINASE; PROTEINASE INHIBITOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; DENDRITIC CELL; ENDOPLASMIC RETICULUM; ENZYME SPECIFICITY; HUMAN; IMMUNE RESPONSE; MACROPHAGE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SHORT SURVEY;

EID: 84885978134     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00299     Document Type: Short Survey

References (43)

1. Watts C. Antigen processing in the endocytic compartment. Curr Opin Immunol (2001) 13:26-31. doi: 10.1016/S0952-7915(00)00177-1.
2. Wolf PR, Ploegh HL. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu Rev Cell Dev Biol (1995) 11:267-306. doi:10.1146/annurev.cb.11.110195.001411.
3. Stumptner-Cuvelette P, Benaroch P. Multiple roles of the invariant chain in MHC class II function. Biochim Biophys Acta (2002) 1542:1-13. doi:10.1016/S0167-4889(01)00166-5.
4. Nakagawa TY, Brissette WH, Lira PD, Griffiths RJ, Petrushova N, Stock J, et al. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity (1999) 10:207-17. doi:10.1016/S1074-7613(00)80021-7.
5. Riese RJ, Wolf PR, Bromme D, Natkin LR, Villadangos JA, Ploegh HL, et al. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity (1996) 4:357-66. doi:10.1016/S1074-7613(00)80249-6.
6. Nakagawa T, Roth W, Wong P, Nelson A, Farr A, Deussing J, et al. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science (1998) 280:450-3. doi:10.1126/science.280.5362.450.
7. Hsieh CS, deRoos P, Honey K, Beers C, Rudensky AY. A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation. J Immunol (2002) 168:2618-25.
8. Pluger EB, Boes M, Alfonso C, Schroter CJ, Kalbacher H, Ploegh HL, et al. Specific role for cathepsin S in the generation of antigenic peptides in vivo. Eur J Immunol (2002) 32:467-76. doi:10.1002/1521-4141(200202)32:2<467::AID-IMMU467>3.0.CO;2-Y.
9. Shi GP, Bryant RA, Riese R, Verhelst S, Driessen C, Li Z, et al. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J Exp Med (2000) 191:1177-86. doi:10.1084/jem.191.7.1177.
10. Stoeckle C, Quecke P, Ruckrich T, Burster T, Reich M, Weber E, et al. Cathepsin S dominates autoantigen processing in human thymic dendritic cells. J Autoimmun (2012) 38:332-43. doi:10.1016/j.jaut.2012.02.003.
11. Zou F, Schafer N, Palesch D, Brucken R, Beck A, Sienczyk M, et al. Regulation of cathepsin G reduces the activation of proinsu1lin-reactive T cells from type 1 diabetes patients. PLoS ONE (2011) 6:e22815. doi:10.1371/journal.pone.0022815.
12. Antoniou AN, Blackwood SL, Mazzeo D, Watts C. Control of antigen presentation by a single protease cleavage site. Immunity (2000) 12:391-8. doi:10.1016/S1074-7613(00)80191-0.
13. Manoury B, Hewitt EW, Morrice N, Dando PM, Barrett AJ, Watts C. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature (1998) 396:695-9. doi:10.1038/25379.
14. Manoury B, Mazzeo D, Fugger L, Viner N, Ponsford M, Streeter H, et al. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Nat Immunol (2002) 3:169-74. doi:10.1038/ni754.
15. Manoury B, Mazzeo D, Li DN, Billson J, Loak K, Benaroch P, et al. Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone. Immunity (2003) 18:489-98. doi:10.1016/S1074-7613(03)00085-2.
16. Maehr R, Hang HC, Mintern JD, Kim YM, Cuvillier A, Nishimura M, et al. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice. J Immunol (2005) 174:7066-74.
17. Matthews SP, Werber I, Deussing J, Peters C, Reinheckel T, Watts C. Distinct protease requirements for antigen presentation in vitro and in vivo. J Immunol (2010) 184:2423-31. doi:10.4049/jimmunol.0901486.
18. Maric M, Arunachalam B, Phan UT, Dong C, Garrett WS, Cannon KS, et al. Defective antigen processing in GILT-free mice. Science (2001) 294:1361-5. doi:10.1126/science.1065500.
19. Rausch MP, Irvine KR, Antony PA, Restifo NP, Cresswell P, Hastings KT. GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1. J Immunol (2010) 185:2828-35. doi:10.4049/jimmunol.1000945.
20. Sealy R, Chaka W, Surman S, Brown SA, Cresswell P, Hurwitz JL. Target peptide sequence within infectious human immunodeficiency virus type 1 does not ensure envelope-specific T-helper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase activities. Clin Vaccine Immunol (2008) 15:713-9. doi:10.1128/CVI.00412-07.
21. West LC, Grotzke JE, Cresswell P. MHC class II-restricted presentation of the major house dust mite allergen Der p 1 Is GILT-dependent: implications for allergic asthma. PLoS ONE (2013) 8:e51343. doi:10.1371/journal.pone.0051343.
22. Haque MA, Li P, Jackson SJ, Zarour HM, Hawes JW, Phan UT, et al. Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominat epitopes. J Exp Med (2002) 195:1267-77. doi:10.1084/jem.20011853.
23. Phipps-Yonas H, Semik V, Hastings KT. GILT expression in B cells diminishes cathepsin S steady-state protein expression and activity. Eur J Immunol (2013) 43:65-74. doi:10.1002/eji.201242379.
24. Sepulveda FE, Maschalidi S, Colisson R, Heslop L, Ghirelli C, Sakka E, et al. Critical role for asparagine endopeptidase in endocytic toll-like receptor signaling in dendritic cells. Immunity (2009) 31:737-48. doi:10.1016/j.immuni.2009.09.013.
25. Shirahama-Noda K, Yamamoto A, Sugihara K, Hashimoto N, Asano M, Nishimura M, et al. Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice. J Biol Chem (2003) 278:33194-9. doi:10.1074/jbc. M302742200.
26. Yi AK, Tuetken R, Redford T, Waldschmidt M, Kirsch J, Krieg AM. CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. J Immunol (1998) 160:4755-61.
27. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol (2002) 20:197-216. doi:10.1146/annurev.immunol.20.083001.084359.
28. Tian T, Avalos AM, Mao SY, Chen B, Senthil H, Wu H, et al. toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and rage. Nat Immunol (2007) 8:487-96. doi:10.1038/ni1457.
29. Ewald SE, Lee BL, Lau L, Wickliffe KE, Shi GP, Chapman HA, et al. The ectodomain of toll-like receptor 9 is cleaved to generate a functional receptor. Nature (2008) 456:658-62. doi:10.1038/nature07405.
30. Matsumoto F, Saitoh S, Fukui R, Kobayashi T, Tanimura N, Konno K, et al. Cathepsins are required for toll-like receptor 9 responses. Biochem Biophys Res Commun (2008) 367:693-9. doi:10.1016/j.bbrc.2007.12.130.
31. Park B, Brinkmann MM, Spooner E, Lee CC, Kim YM, Ploegh HL. Proteolytic cleavage in an endolysosomal compartment is required for activation of toll-like receptor 9. Nat Immunol (2008) 9:1407-14. doi:10.1038/ni.1669.
32. Asagiri M, Hirai T, Kunigami T, Kamano S, Gober HJ, Okamoto K, et al. Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. Science (2008) 319:624-7. doi:10.1126/science.1150110.
33. Ewald SE, Engel A, Lee J, Wang M, Bogyo M, Barton GM. Nucleic acid recognition by toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase. J Exp Med (2011) 208:643-51. doi:10.1084/jem.20100682.
34. Maschalidi S, Hassler S, Blanc F, Sepulveda FE, Tohme M, Chignard M, et al. Asparagine endopeptidase controls anti-influenza virus immune responses through TLR7 activation. PLoS Pathog (2012) 8:e1002841. doi:10.1371/journal.ppat.1002841.
35. Kanno A, Yamamoto C, Onji M, Fukui R, Saitoh S, Motoi Y, et al. Essential role for toll-like receptor 7 (TLR7)-unique cysteines in an intramolecular disulfide bond, proteolytic cleavage and RNA sensing. Int Immunol (2013) 25:413-22. doi:10.1093/intimm/dxt007.
36. Qi R, Singh D, Kao CC. Proteolytic processing regulates toll-like receptor 3 stability and endosomal localization. J Biol Chem (2012) 287:32617-29. doi:10.1074/jbc. M112.387803.
37. Toscano F, Estornes Y, Virard F, Garcia-Cattaneo A, Pierrot A, Vanbervliet B, et al. Cleaved/associated TLR3 represents the primary form of the signaling receptor. J Immunol (2013) 190:764-73. doi:10.4049/jimmunol.1202173.
38. Garcia-Cattaneo A, Gobert FX, Muller M, Toscano F, Flores M, Lescure A, et al. Cleavage of toll-like receptor 3 by cathepsins B and H is essential for signaling. Proc Natl Acad Sci U S A (2012) 109:9053-8. doi:10.1073/pnas.1115091109.
39. Brinkmann MM, Spooner E, Hoebe K, Beutler B, Ploegh HL, Kim YM. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol (2007) 177:265-75. doi:10.1083/jcb.200612056.
40. Kim YM, Brinkmann MM, Paquet ME, Ploegh HL. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature (2008) 452:234-8. doi:10.1038/nature06726.
41. Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, Yang K, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science (2006) 314:308-12. doi:10.1126/science.1128346.
42. Tabeta K, Hoebe K, Janssen EM, Du X, Georgel P, Crozat K, et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via toll-like receptors 3, 7 and 9. Nat Immunol (2006) 7:156-64. doi:10.1038/ni1297.
43. Liu X, Zhan Z, Li D, Xu L, Ma F, Zhang P, et al. Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat Immunol (2011) 12:416-24. doi:10.1038/ni.2015.